You just read:

Daewoong Pharmaceutical Unveils Phase 3 Clinical Data of Fexuprazan, A Novel Potassium-competitive Acid Blocker

News provided by

Daewoong Pharmaceutical Co., Ltd

May 08, 2020, 09:00 ET